alpha-aminopyridine has been researched along with incb-018424 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnel, D; Eriksson, AH; Legouffe, R; Mortensen, RW; Nielsen, KT; Pamelard, F; Stauber, J | 1 |
| Bharathy, S; Chuah, C; Dong, T; Durrant, ST; Gisslinger, H; Guglielmelli, P; Lavie, D; le Coutre, P; Lopez, JM; Maffioli, M; Nagler, A; Wroclawska, M | 1 |
| Chat, VS; Kearns, DG; Uppal, SK; Wu, JJ | 1 |
| Almonte, M; Charania, A; Cherlin, S; Cook, L; Cooke, G; Cooper, N; Cornelius, V; Innes, AJ; Katsarou, A; Kon, OM; Milojkovic, D; Phillips, R; Pilay, C; Shturova, T; Thursz, M; Turner, R; Vergis, N; Wason, J; Willicombe, M; Youngstein, T | 1 |
| Lé, AM; Torres, T | 1 |
2 review(s) available for alpha-aminopyridine and incb-018424
| Article | Year |
|---|---|
Topical Agents Currently in Phase II or Phase III Trials for Atopic Dermatitis.
Topics: Administration, Cutaneous; Aminopyridines; Benzamides; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Dermatitis, Atopic; Dermatologic Agents; Humans; Nitriles; Pyrazoles; Pyrimidines; Resorcinols; Severity of Illness Index; Skin Cream; Stilbenes; Treatment Outcome | 2020 |
New Topical Therapies for Psoriasis.
Topics: Administration, Topical; Aminopyridines; Amygdalin; Benzamides; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dermatologic Agents; Humans; Interleukin-2; MicroRNAs; Nitriles; Phosphodiesterase 4 Inhibitors; Piperidines; Psoriasis; Pyrazoles; Pyrimidines; Resorcinols; Stilbenes | 2022 |
2 trial(s) available for alpha-aminopyridine and incb-018424
| Article | Year |
|---|---|
Results from HARMONY: an open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Morpholines; Nitriles; Primary Myelofibrosis; Prognosis; Pyrazoles; Pyrimidines; Tissue Distribution | 2019 |
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.
Topics: Adult; Aminopyridines; COVID-19 Drug Treatment; Humans; Morpholines; Nitriles; Oxazines; Pandemics; Pyrazoles; Pyridines; Pyrimidines; Randomized Controlled Trials as Topic; Respiration, Artificial; Treatment Outcome; Venous Thromboembolism | 2021 |
1 other study(ies) available for alpha-aminopyridine and incb-018424
| Article | Year |
|---|---|
MALDI imaging facilitates new topical drug development process by determining quantitative skin distribution profiles.
Topics: Acetamides; Administration, Topical; Aminopyridines; Benzamides; Cyclopropanes; Drug Discovery; Humans; Nitriles; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Skin; Skin Absorption; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |